You Searched For "cipla gilead" and got 14 results
Sort By:
2 mins read
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
1 min read
Cipla launches generic remdesivir for COVID-19 patients
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
1 min read
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
The EUA is based on available data from two global clinical trials – US National Institute for All…
PTI
2 mins read
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
1 min read
Cipla shares gain over 3 pc as co launches generic remdesivir for COVID-19 patients
Remdesivir is the only USFDA-approved EUA for treatment for adult and paediatric patients hospitali…
PTI
2 mins read
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
3 mins read
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
2 mins read
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
1 min read
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for rest…
PTI
4 mins read
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
2 mins read
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
5 mins read
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
2 mins read
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
2 mins read
Hetero Healthcare set to supply its generic COVID-19 drug at Rs 5,400 per vial across India
"The launch of Covifor in India is a significant milestone for all of us... Through Covifor, we ho…